Cardiovascular Events in Patients Treated with Chimeric Antigen Receptor T-cell Therapy for Aggressive B-cell Lymphoma

The authors retrospectively reviewed the characteristics and outcomes of adult patients with relapsed/refractory large B-cell lymphoma treated with Standard of care axicabtagene ciloleucel or tisagenlecleucel .